Skylight Health Group Inc.
SLHGF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | 0.03 | -0.01 | 0.16 |
| FCF Yield | -3.31% | -14.34% | -12.70% | -5.27% |
| EV / EBITDA | -14.95 | -19.52 | -9.52 | -7.37 |
| Quality | ||||
| ROIC | -9.89% | -11.11% | -16.13% | -18.55% |
| Gross Margin | -10.70% | 24.70% | 44.44% | -180.76% |
| Cash Conversion Ratio | 0.21 | 0.67 | 0.79 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 51.43% | 37.22% | 25.73% | 16.65% |
| Free Cash Flow Growth | 73.64% | 46.53% | -92.64% | 8.24% |
| Safety | ||||
| Net Debt / EBITDA | -8.28 | -10.69 | -1.66 | -0.49 |
| Interest Coverage | -3.71 | -7.39 | -20.71 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 20.75 | 74.62 | 58.32 | 977.05 |